March 19, 2019
Allergan expands label for Avycaz, for intra-abdominal infections
Allergan has expanded the label of Avycaz, as it got approval from the US FDA for its supplemental New Drug Application (sNDA), for treating young patients with complicated intra-abdominal infections.